Speakers
Parallel session
Chair: Katherine Hayden
Development of an UPLC-MS assay to measure hydroxycarbazepine, the active metabolite of the anti-epileptic drugs oxcarbazepine and eslicarbazepine acetate, Sally Hanton
Measurement of salivary cortisone by LC-MS, for the exclusion of adrenal insufficiency, Gregory Bulmer
Determination of Parathyroid Hormone Reference Interval Using Laboratory Data in a UK Paediatric Population, Leanne Wherret
Evaluation of PCSK9 inhibitors in patients with hyperlipidaemia, May Oo Khin
Is dysregulated iron homeostasis a risk factor for non-alcoholic fatty liver disease?, Emma Ashley
Kath Hayden is a Consultant Clinical Biochemist at Manchester University NHS Foundation Trust and Honorary Senior Lecturer at the University of Manchester.
Following training in South Manchester, Kath has held posts in hospitals in Manchester and Liverpool over a 35 year period, overseeing significant advances in analytical technologies, point of care testing (POCT) and harmonisation of laboratories. With specialist interests in endocrinology, POCT, leadership and service improvement, her latest roles have been as Clinical Head of Division for Laboratory Medicine at Manchester University NHS Foundation Trust, Trust Lead Healthcare Scientist, Clinical Director for Laboratory Medicine and Head of Service for Clinical Biochemistry at Central Manchester University Hospitals NHS Foundation Trust.
Pronouns: She/her